RxNews Recap for Wednesday 01-06-10 Print E-mail
By Mary Davila   
Wednesday, 06 January 2010 19:50

Below is a list of the companies that made news in the healthcare sector on Wednesday, January 06, 2010.

Biotech investors interested in seeing more details about these companies and a full list of their related stories can do so by typing the stock ticker symbol into the Stock Quotes box on the right side of the page.

Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by JPMorgan on Wednesday, January 13, 2010 at 8:30 a.m. PT (12:30 a.m. ET) from the Westin St. Francis Hotel in San Francisco.

Beeline, the workforce solutions business unit of MPS Group, Inc. (NYSE:MPS), today announced that it has won a second Brandon Hall Gold Award for Excellence in the Best Custom Content category.

BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that effective December 31, 2009, the Company amended and restated its manufacturing and supply agreement with Novartis Vaccines and Diagnostics, Inc. for the supply of bulk rhPDGF-BB to BioMimetic.

Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the 28th Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco.

Catalyst Health Solutions, Inc. (NASDAQ: CHSI) announced today that David T. Blair, Chief Executive Officer, Richard A. Bates, Executive Vice President and Hai Tran, Chief Financial Officer, are scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010, at approximately 2:30 p.m. PT in San Francisco.

Celgene Corporation (NASDAQ: CELG) today announced its presentation at the 28th Annual JPMorgan Healthcare Conference on Monday, January 11, 2010 at 8:00 AM PST (11:00 AM EST) will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com.

Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the 28th Annual J.P. Morgan Healthcare Conference.

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that the first patient has been treated in the Phase 2 studies of PEG-SN38 for metastatic breast cancer.

Ensemble Discovery today announced the initiation of a strategic alliance with Pfizer Inc. (NYSE: PFE) to discover and develop drug candidates of a novel class against a number of high-value pharmaceutical targets.

Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the 28th Annual J.P. Morgan Healthcare Conference to be held on January 11-14, 2010 in San Francisco.

Human Genome Sciences, Inc. (NASDAQ: HGSI) announced today that its presentation at the 28th Annual JPMorgan Healthcare Conference will be webcast and may be accessed at www.hgsi.com.

ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference at 9:30 am PST on January 14, 2010.

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) announced today that on Dec. 31, 2009, it granted options to purchase a total of 5,000 shares of MiddleBrook's common stock to two (2) new employees as a material inducement for them to join MiddleBrook.

MedLink (OTCBB: MLKNA) announced today that the MedLink EHR has been "qualified" by the Centers for Medicare and Medicaid Services (CMS) for eligible providers to submit quality data to CMS for 2010 PQRI reporting.MedLink went through a thorough vetting process during 2009 with CMS to demonstrate MedLink TotalOffice EHR's capability to provide the required PQRI data elements for 10 PQRI and electronic prescribing measures.

Obagi Medical Products, Inc. (Nasdaq: OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today that Preston Romm, the Company's Chief Financial Officer and EVP, Finance, Operations and Administration will present a corporate overview at the 28th Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco.

OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that OSI Management will present at the JP Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 12th at 3:00pm (Pacific Time) and will provide an overview on the Company’s product portfolio and business developments.

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a vertically–integrated supplier of hybrid and genetically – modified crop seeds in China, will announce audited financial results for the fiscal year ended September 30, 2009 on January 14, 2010.

SDI (Strategic Diagnostics Inc., Nasdaq: SDIX), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.

Walgreens (NYSE: WAG)(NASDAQ: WAG), the nation’s largest drugstore chain, has signed an agreement with Genpact (NYSE: G), a leader in managing business processes for companies around the world, to provide Walgreens with accounting services.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus